Your browser doesn't support javascript.
loading
Evaluation of the Antioxidant Capacity and Protective Effects of a Comprehensive Topical Antioxidant Containing Water-soluble, Enzymatic, and Lipid-soluble Antioxidants.
McDaniel, David H; Waugh, Jacob M; Jiang, Lily I; Stephens, Thomas J; Yaroshinsky, Alex; Mazur, Chris; Wortzman, Mitchell; Nelson, Diane B.
Affiliation
  • McDaniel DH; Dr. McDaniel and Mr. Mazur are with the McDaniel Institute of Anti-Aging Research in Virginia Beach, Virginia.
  • Waugh JM; Dr. Waugh is with Illustris Pharmaceuticals, Inc. in Palo Alto, California.
  • Jiang LI; Drs. Jiang and Stephens are with Thomas J. Stephens & Associates, Inc. in Richardson, Texas.
  • Stephens TJ; Dr. Yaroshinsky is with Vital Systems, Inc. in Rolling Meadows, Illinois.
  • Yaroshinsky A; Dr. Wortzman and Ms. Nelson are with skinbetter science in Phoenix, Arizona.
  • Mazur C; Dr. McDaniel and Mr. Mazur are with the McDaniel Institute of Anti-Aging Research in Virginia Beach, Virginia.
  • Wortzman M; Dr. Waugh is with Illustris Pharmaceuticals, Inc. in Palo Alto, California.
  • Nelson DB; Drs. Jiang and Stephens are with Thomas J. Stephens & Associates, Inc. in Richardson, Texas.
J Clin Aesthet Dermatol ; 12(4): 46-53, 2019 Apr.
Article in En | MEDLINE | ID: mdl-31119011
Objectives: Investigators sought to evaluate the antioxidant capacity of a comprehensive topical antioxidant (WEL-DS), its ability to protect skin against the oxidizing effects of UVA/UVB radiation, and to assess the effectiveness and tolerability of WEL-DS for visible improvements in facial photodamage. Study Designs: In-vitro testing utilized a hydrogen peroxide assay to detect activity in human skin explants following application with WEL-DS, a leading antioxidant serum (L-AOX), and a saline control. Clinical studies included a minimal erythema dose (MED) trial in female subjects, aged 35 to 60 years. Skin was initially irradiated to determine each subject's MED. WEL-DS was applied for four days to one site on the lower back of subjects; the other site remained untreated. Both sites were irradiated with 1X, 2X and 3X each subject's MED, digital images were obtained, and punch biopsies were collected from the 3X MED irradiated areas for histological analysis. A second clinical study evaluated efficacy and tolerability of twice daily application of WEL-DS in female subjects, aged 25 to 65 years with mild-to-moderate photodamage. Changes in fine lines/ wrinkles, dyschromia, erythema, skin tone, pores, and tolerability were assessed at baseline and Weeks 4, 8, and 12. A subset of subjects were evaluated through Week 16. Results: Skin treated with WEL-DS neutralized up to 53 percent more oxidative stress relative to L-AOX. WEL-DS-treated skin demonstrated significantly less UV-induced erythema at 1X, 2X, and 3X MED and demonstrated cellular protective effects versus untreated irradiated skin (N=5). WEL-DS demonstrated average improvements from baseline of 37 percent, fine lines/ wrinkles; 17 percent, skin tone; 13 percent, dyschromia; 18 percent, erythema; and four percent, pores (N=21; Week 12). Continued improvements were demonstrated in all parameters in an extension study (n=14; week 16). WEL-DS was well-tolerated. Conclusion: These studies demonstrate WEL-DS's innate ability to quench free radicals, protect skin from the oxidizing effects of UV radiation, and reduce the visible effects of facial photodamage.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Aesthet Dermatol Year: 2019 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Clin Aesthet Dermatol Year: 2019 Document type: Article Country of publication: United States